Pilot study of combination therapy with ribavirin and interferon alfa for the retreatment of chronic hepatitis B e antibody-positive patients

Hepatology

Volumn 31, Issue 2, 2000, Pages 502-506

  Cotonat, Teresa ^a,b   Quiroga, Juan Antonio ^a,b   López Alcorocho, Juan Manuel ^a,b   Clouet, Rosa ^a   Pardo, Margarita ^a,b   Manzarbeitia, Félix ^a   Carreño, Vicente ^a,b  

^a Hospital UniversitarioFundación Jiménez Díaz   (Spain)

^b Hospital Pardo de Aravaca   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIBODY; RECOMBINANT ALPHA2B INTERFERON; RIBAVIRIN;

ADULT; ARTICLE; CLINICAL ARTICLE; DRUG EFFICACY; DRUG SAFETY; FEMALE; FLU LIKE SYNDROME; FOLLOW UP; HEPATITIS B; HUMAN; HUMAN TISSUE; MALE; NEUTROPENIA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

EID: 0033967583     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510310234     Document Type: Article

References (26)

1. Hoofnagle JH, di Bisceglie AM. The treatment of chronic viral hepatitis. N Engl J Med 1997;336:347-356.
2. Carreño V, Castillo I, Molina J, Porres JC, Bartolome J. Long-term follow-up of hepatitis B chronic carriers who responded to interferon therapy. J Hepatol 1992;15:102-106.
3. Carman WF, Jacyna MR, Hadziyannis S, Karayiannis P, McGarvey MJ, Makris A, Thomas HC. Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection. Lancet 1989;ii:588-591.
4. Brunetto MR, Giarin M, Saracco G, Oliveri F, Calvo P, Capra G, Randone A, et al. Hepatitis B virus unable to secrete e antigen and response to interferon in chronic hepatitis B. Gastroenterology 1993;105:845-850.
5. Hadziyannis S, Bramou T, Makris A, Moussoulis G, Zignego L, Papaioannou C. Interferon alfa-2b treatment of HBeAg negative/serum HBV DNA positive chronic active hepatitis type B. J Hepatol 1990;11(Suppl 1):133-136.
6. Fattovich G, Farci P, Rugge M, Brollo L, Mandas A, Pontisso P, Giustina G, et al. A randomized controlled trial of lymphoblastoid interferon-alpha in patients with chronic hepatitis B lacking HBeAg. HEPATOLOGY 1992;15:584-589.
7. López-Alcorocho JM, Bartolomé J, Cotonat T, Carreño V. Efficacy of prolonged interferon-alpha treatment in chronic hepatitis B patients with HBeAb: comparison between 6 and 12 months of therapy. J Viral Hepat 1997;4(Suppl 1):27-32.
8. Arase Y, Chayama K, Tsubota A, Murashima N, Suzuki Y, Koida I, Kobayashi M, et al. A randomized, double-blind, controlled trial of natural interferon-beta therapy for e-antigen-negative chronic hepatitis B patients with abnormal transaminase levels. J Gastroenterol 1996;31:559-564.
9. López-Alcorocho JM, Cabrerizo M, Bartolomé J, Cotonat T, Carreño V. Analysis of hepatitis B virus precore variants in hepatitis B e antibody-positive patients treated with prednisone plus interferon. J Viral Hepat 1995;2:279-284.
10. Tassopoulos NC, Volpes R, Pastore G, Heathcote J, Buti M, Goldin RD, Hawley S, et al. Efficacy of lamivudine in patients with hepatitis B e antigen-negative/hepatitis B virus DNA-positive (precore mutant) chronic hepatitis B. Lamivudine Precore Mutant Study Group. HEPATOLOGY 1999;29:889-896.
11. Hultgren C, Milich DR, Weiland O, Sallberg M. The antiviral compound ribavirin modulates the T helper (Th) 1/Th2 subset balance in hepatitis B and C virus-specific immune responses. J Gen Virol 1998;79:2381-2391.
12. Martin J, Navas S, Quiroga JA, Pardo M, Carreno V. Effects of the ribavirin-interferon alpha combination on cultured peripheral blood mononuclear cells from chronic hepatitis C patients. Cytokine. 1998;10:635-644.
13. Davis GL, Esteban-Mur R, Rustgi V, Hoefs J, Gordon SC, Trepo C, Shiffman ML, et al. Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group. N Engl J Med 1998;339:1493-1499.
14. Jain S, Thomas HC, Oxford JS, Sherlock S. Trial of ribavirin for the treatment of HBsAg positive chronic liver disease. J Antimicrob Chemother 1978;4:367-373.
15. Fried MW, Fong TL, Swain MG, Park Y, Beames MP, Banks SM, Hoofnagle JH, et al. Therapy of chronic hepatitis B with a 6-month course of ribavirin. J Hepatol 1994;21:145-150.
16. Kakumu S, Yoshioka K, Wakita T, Ishikawa T, Takayanagi M, Higashi Y. Pilot study of ribavirin and interferon-beta for chronic hepatitis B. HEPATOLOGY 1993;18:258-263.
17. Scheuer PJ, Davies SE, Dhillon AP. Histopathological aspects of viral hepatitis. J Viral Hepat 1996;3:277-283.
18. Gerken G, Gomes J, Lampertico P, Colombo M, Rothaar T, Trippler M, Colucci G. Clinical evaluation and applications of the Amplicor HBV Monitor test, a quantitative HBV DNA PCR assay. J Virol Methods 1998;74:155-165.
19. Oliveri F, Santantonio T, Bellati G, Colombatto P, Mels GC, Carriero L, Dastoli G, et al. Long term response to therapy of chronic anti-HBe-positive hepatitis B is poor independent of type and schedule of interferon. Am J Gastroenterol 1999;94:1366-1372.
20. Tassopoulos NC, Volpes R, Pastore G, Heathcote J, Buti M, Gray DF, Barber J, et al. Post lamivudine treatment follow-up of patients with HBeAg-negative chronic hepatitis B [Abstract]. J Hepatol 1999;30(Suppl 1):117.
21. Faltovich G, Giustina G, Schalm SW, Hadziyannis S, Sanchez-Tapias J, Almasio P, Christensen E, et al. Occurrence of hepatocellular carcinoma and decompensation in western European patients with cirrhosis type B. The EUROHEP Study Group on Hepatitis B Virus and Cirrhosis. HEPATOLOGY 1995;21:77-82.
22. Alberti A, Chemello L,. Pontisso P, Benvegnù L, Bernardinello E, Cavalletto L. Interferon therapy for chronic viral hepatitis: status report. In: Rizzetto M, Purcell RH, Gerin JL, Verme G, eds. Viral Hepatitis and Liver Disease, Turin, Italy: Edizioni Minerva Medica 1997:727-735.
23. Brunetto MR, Oliveri F, Colombatto P, Capalbo M, Barbera C, Bonino F. Treatment of chronic anti-HBe-positive hepatitis B with interferon-alpha. J Hepatol 1995;22(Suppl 1):42-44.
24. Lai CL, Chien RN, Leung NW, Chang TT, Guan R, Tai DI, Ng KY, et al. A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group. N Engl J Med 1998;339:61-68.
25. Lok AS, Chung HT, Liu VW, Ma OC. Long-term follow-up of chronic hepatitis B patients treated with interferon alfa. Gastroenterology 1993;105:1833-1838.
26. Mangia A, Chung YH, Hoofnagle JH, Birkenmeyer L, Mushahwar I, Di Bisceglie AM. Long-term follow-up of patients with chronic hepatitis B treated with interferon alfa. Gastroenlerology 1997;113:1660-1667.